Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class ...

The number of people receiving treatment for cancer has risen dramatically in the last decade in many African countries. For ...

Compugen’s Unigen AI/ML platform drives the discovery of potentially novel checkpoints. Find out what nudges me to rate CGEN ...

The 2025 edition of the European Society for Medical Oncology(ESMO) was held this week in Berlin, delve into its key ...

Recent studies presented at the European Society for Medical Oncology meeting showcase promising results of antibody-drug conjugates (ADCs) in breast cancer treatment. Trials reveal significantly ...

A newer class of cancer drugs can delay disease progression or extend survival for breast cancer patients, multiple teams of ...

The confirmed presence of substandard or falsified anticancer medicines in sub-Saharan Africa will complicate cancer care.

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from ...

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from small lesions or polyps, its exact causes are unknown — only a few risk factors ...

Merck KGaA could now have a head start in the race to market Precem-TcT, which could become the first widely approved ADC in ...